Advertisement
UK markets open in 3 hours 12 minutes
  • NIKKEI 225

    38,392.10
    +189.73 (+0.50%)
     
  • HANG SENG

    18,529.18
    +215.32 (+1.18%)
     
  • CRUDE OIL

    79.42
    +0.43 (+0.54%)
     
  • GOLD FUTURES

    2,319.80
    -2.50 (-0.11%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • Bitcoin GBP

    49,304.51
    -1,060.12 (-2.10%)
     
  • CMC Crypto 200

    1,310.76
    +16.09 (+1.24%)
     
  • NASDAQ Composite

    16,302.76
    -29.80 (-0.18%)
     
  • UK FTSE All Share

    4,544.24
    +21.25 (+0.47%)
     

2 Under-the-Radar Stocks to Buy Now

2 Under-the-Radar Stocks to Buy Now

COVID-19 testing company Lucira Health became public only in February, but it has been plagued by problems since. Lucira's flagship device is a single-use, do-it-yourself COVID-19 test kit that received regulatory clearance for over-the-counter use in April. Overall, it was a major innovation by Lucira Health, but it came a tad bit too late.